ANZAC: A NEOADJUVANT BIOMARKER STUDY EXPLORING THE ANTI-TUMOUR ACTIVITY OF THE ADDITION OF ZOLEDRONIC ACID TO CHEMOTHERAPY IN BREAST CANCER

被引：0
|
作者：
Winter, M. C.
Cross, S. S. [1 ]
Ingram, C. E. [2 ]
Jolley, I. J. [2 ]
Holen, I. [3 ]
Hatton, M. Q. [4 ]
Horsman, J. M.
Coleman, R. [5 ]
机构：
[1] Univ Sheffield, Royal Hallamshire Hosp, Acad Unit Pathol, Sheffield S10 2JF, S Yorkshire, England
[2] Sheffield Teaching Hosp, NHS Fdn Trust, Royal Hallamshire Hosp, Dept Radiol, Sheffield, S Yorkshire, England
[3] Univ Sheffield, Acad Unit Clin Oncol, Bone Oncol Labs, Sheffield, S Yorkshire, England
[4] Sheffield Teaching Hosp, NHS Fdn Trust, Weston Pk Hosp, Dept Clin Oncol, Sheffield, S Yorkshire, England
[5] Weston Pk Hosp, Canc Res Ctr, Sheffield, S Yorkshire, England
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [1] ANZAC: A Randomised Neoadjuvant Biomarker Study Investigating the Anti-Tumour Activity of the Addition of Zoledronic Acid to Chemotherapy in Breast Cancer
    Winter, M. C.
    Syddall, S. P.
    Cross, S. S.
    Evans, A.
    Ingram, C. E.
    Jolley, I. J.
    Hatton, M. Q.
    Mori, S.
    Holen, I.
    Coleman, R. E.
    [J]. CANCER RESEARCH, 2010, 70
  • [2] The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
    Coleman, R. E.
    Winter, M. C.
    Cameron, D.
    Bell, R.
    Dodwell, D.
    Keane, M. M.
    Gil, M.
    Ritchie, D.
    Passos-Coelho, J. L.
    Wheatley, D.
    Burkinshaw, R.
    Marshall, S. J.
    Thorpe, H.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (07) : 1099 - 1105
  • [3] The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
    R E Coleman
    M C Winter
    D Cameron
    R Bell
    D Dodwell
    M M Keane
    M Gil
    D Ritchie
    J L Passos-Coelho
    D Wheatley
    R Burkinshaw
    S J Marshall
    H Thorpe
    [J]. British Journal of Cancer, 2010, 102 : 1099 - 1105
  • [4] Anti-tumour activity of zoledronic acid
    Clézardin, P
    [J]. CANCER TREATMENT REVIEWS, 2005, 31 : S1 - S8
  • [5] Exploring the anti-tumour activity of bisphosphonates in early breast cancer
    Winter, M. C.
    Holen, I.
    Coleman, R. E.
    [J]. CANCER TREATMENT REVIEWS, 2008, 34 (05) : 453 - 475
  • [6] Exploring the anti-angiogenic potential of zoledronic acid in combination with neoadjuvant chemotherapy in invasive breast cancer
    Winter, M. C.
    Evans, A.
    Holen, I.
    Coleman, R. E.
    [J]. BONE, 2010, 47 : S310 - S310
  • [7] Neoadjuvant Chemotherapy with or without Zoledronic Acid in Early Breast Cancer-A Randomized Biomarker Pilot Study
    Winter, Matthew C.
    Wilson, Caroline
    Syddall, Stuart P.
    Cross, Simon S.
    Evans, Alyson
    Ingram, Christine E.
    Jolley, Ingrid J.
    Hatton, Matthew Q.
    Freeman, Jennifer V.
    Mori, Stefano
    Holen, Ingunn
    Coleman, Robert E.
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (10) : 2755 - 2765
  • [8] Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid
    Marra, M.
    Santini, D.
    Tonini, G.
    Meo, G.
    Zappavigna, S.
    Facchini, G.
    Morabito, A.
    Abbruzzese, A.
    Carteni, G.
    Budillon, A.
    Caraglia, M.
    [J]. EJC SUPPLEMENTS, 2008, 6 (14): : 79 - 85
  • [9] Potential influence of zoledronic acid on primary tumour response during neoadjuvant chemotherapy for breast cancer
    Winter, Matthew
    Thorpe, Helen
    Burkinshaw, Roger
    Beevers, Samantha
    Coleman, Robert
    [J]. CANCER TREATMENT REVIEWS, 2008, 34 : S55 - S56
  • [10] The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer
    Morgan, Claire
    Lewis, Paul D.
    Jones, Rachel M.
    Bertelli, Gianfilippo
    Thomas, Gerry A.
    Leonard, Robert C. F.
    [J]. ACTA ONCOLOGICA, 2007, 46 (05) : 669 - 677
12345